689 related articles for article (PubMed ID: 24107075)
1. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
[TBL] [Abstract][Full Text] [Related]
2. Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs.
Salehi R; Hamishehkar H; Eskandani M; Mahkam M; Davaran S
J Drug Target; 2014 May; 22(4):327-42. PubMed ID: 24404962
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
4. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
5. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
Ofner CM; Pica K; Bowman BJ; Chen CS
Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of New Antibacterial Cubane-based Nanocomposite and its Application in Combination Cancer Therapy.
Zakerzadeh E; Salehi R; Mahkam M
Anticancer Agents Med Chem; 2018 Feb; 17(14):1898-1914. PubMed ID: 28530541
[TBL] [Abstract][Full Text] [Related]
8. Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
Curcio M; Blanco-Fernández B; Costoya A; Concheiro A; Puoci F; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2015 Jun; 93():281-92. PubMed ID: 25917641
[TBL] [Abstract][Full Text] [Related]
9. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer.
Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR
Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic synthesized nanoporous silica@poly(ethyleneimine)s xerogel as drug carrier: characteristics and controlled release effect.
Li J; Xu L; Liu H; Wang Y; Wang Q; Chen H; Pan W; Li S
Int J Pharm; 2014 Jun; 467(1-2):9-18. PubMed ID: 24674897
[TBL] [Abstract][Full Text] [Related]
11. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
Vadia N; Rajput S
Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
[TBL] [Abstract][Full Text] [Related]
12. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.
Hosseini Sadr S; Davaran S; Alizadeh E; Salehi R; Ramazani A
J Biomater Sci Polym Ed; 2018 Feb; 29(3):277-308. PubMed ID: 29212412
[TBL] [Abstract][Full Text] [Related]
15. pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging.
Farshbaf M; Salehi R; Annabi N; Khalilov R; Akbarzadeh A; Davaran S
Drug Dev Ind Pharm; 2018 Mar; 44(3):452-462. PubMed ID: 29098882
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
[TBL] [Abstract][Full Text] [Related]
17. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I
Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity and drug release properties of pH- and temperature-sensitive core-shell hydrogel microspheres.
Ma L; Liu M; Liu H; Chen J; Cui D
Int J Pharm; 2010 Jan; 385(1-2):86-91. PubMed ID: 19879345
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of pH-sensitive magnetic nanocomposites as methotrexate delivery system for targeted cancer therapy.
Wu J; Deng A; Jiang W; Tian R; Shen Y
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():132-140. PubMed ID: 27987687
[TBL] [Abstract][Full Text] [Related]
20. Surface modification of graphene oxide with stimuli-responsive polymer brush containing β-cyclodextrin as a pendant group: Preparation, characterization, and evaluation as controlled drug delivery agent.
Pooresmaeil M; Namazi H
Colloids Surf B Biointerfaces; 2018 Dec; 172():17-25. PubMed ID: 30121487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
